Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $657.9200 (-0.21%) ($657.9200 - $661.1000) on Thu. May. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.66% (three month average) | RSI | 48 | Latest Price | $657.9200(-0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 0.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(38%) IWD(37%) XLV(36%) SPLV(35%) | Factors Impacting REGN price | REGN will decline at least -0.83% in a week (0% probabilities). VIXM(-14%) TBT(-11%) UUP(-6%) VXX(-2%) USO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.83% (StdDev 1.66%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $656.82(0.17%) | 10 Day Moving Average | $638.15(3.1%) | 20 Day Moving Average | $651.22(1.03%) | To recent high | -11% | To recent low | 9.7% | Market Cap | $69.758b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |